Arian Emami Riedmaier
- Oncology top 10%
- Molecular Biology
- Pharmacology top 5%
- Pediatrics, Perinatology and Child Health top 10%
- Pharmaceutical Science top 5%
- Co-authors
- Matthias SchwabAnne T. NiesElke SchaeffelerPascale FiselHoward BurtSibylle NeuhoffNeil ParrottXavier Pépin
- Topics
- Drug Transport and Resistance Mechanisms (7 papers)Pharmacological Effects and Toxicity Studies (4 papers)Drug Solubulity and Delivery Systems (3 papers)
- Journals
- Pharmacological ReviewsTrends in Pharmacological SciencesJournal of Pharmaceutical Sciences
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Arian Emami Riedmaier
12 papers receiving 590 citations
Peers
Comparison fields: 5 of 74
- Oncology 287
- Molecular Biology 212
- Pharmacology 152
- Pediatrics, Perinatology and Child Health 134
- Pharmaceutical Science 106
Countries citing papers authored by Arian Emami Riedmaier
This map shows the geographic impact of Arian Emami Riedmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arian Emami Riedmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arian Emami Riedmaier more than expected).
Fields of papers citing papers by Arian Emami Riedmaier
This network shows the impact of papers produced by Arian Emami Riedmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arian Emami Riedmaier. The network helps show where Arian Emami Riedmaier may publish in the future.
Co-authorship network of co-authors of Arian Emami Riedmaier
This figure shows the co-authorship network connecting the top 25 collaborators of Arian Emami Riedmaier. A scholar is included among the top collaborators of Arian Emami Riedmaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arian Emami Riedmaier. Arian Emami Riedmaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 9 | |
| 3 | 28 | |
| 4 | 28 | |
| 5 | 7 | |
| 6 | 19 | |
| 7 | 110 | |
| 8 | 58 | |
| 9 | 59 | |
| 10 | 34 | |
| 11 | 137 | |
| 12 | 101 |
About Arian Emami Riedmaier
Arian Emami Riedmaier is a scholar working on Pharmaceutical Science, Transplantation and Statistics and Probability, having authored 12 papers that have together received 601 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Drug Solubulity and Delivery Systems (3 papers). The work is most often cited by research in Pharmaceutical Science (106 citations), Pharmacology (152 citations) and Oncology (287 citations). Arian Emami Riedmaier has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Matthias Schwab, Anne T. Nies, Elke Schaeffeler, Pascale Fisel, Howard Burt, Sibylle Neuhoff, Neil Parrott, Xavier Pépin, Matthew D. Harwood and Katherine L. Gill. Their work appears in journals such as Pharmacological Reviews, Trends in Pharmacological Sciences and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.